Skip to content

Expiring federal contract

HT001424P0068 — Biocare Medical LLC

Department of Defense · Defense Health Agency

Contract / PIID
HT001424P0068
Incumbent
Biocare Medical LLC
Incumbent UEI
MS7LZ6JPYNQ5
Current end date
March 24, 2027
Potential total value
$225,275
Obligated
$225,275
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
PSC
6505 — DRUGS AND BIOLOGICALS
Set-aside
Full & Open
Start date
March 25, 2024
Place of performance
MD
Award type
PURCHASE ORDER

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

ANTIBODIES

Likely rebid window (estimate)

  • Sources Sought / RFI: about Mar 2026 – Sep 2026 (6–12 months before the end date)
  • RFP: about Nov 2026 – Jan 2027 (2–4 months before the end date)

Between the estimated Sources Sought and RFP windows.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Defense (NAICS 325413)